Medicare Enrolled

Dr. Sylvia Zuniga-Barboni, M.D.

Neurology · Palm Beach Gardens, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
3400 BURNS RD STE 101, Palm Beach Gardens, FL 33410
5616261159
In practice since 2006 (19 years)
NPI: 1073578209 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Zuniga-Barboni from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zuniga-Barboni? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Zuniga-Barboni

Dr. Sylvia Zuniga-Barboni is a neurology in Palm Beach Gardens, FL, with 19 years in practice. Based on federal Medicare data, Dr. Zuniga-Barboni performed 1,347 Medicare services across 1,130 unique beneficiaries.

Between the years covered by Open Payments, Dr. Zuniga-Barboni received a total of $9,037 from 52 pharmaceutical and/or device companies across 490 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Zuniga-Barboni is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 25% volume in FL$ $9,037 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,347
Medicare services
Top 25% in FL for neurology
1,130
Unique beneficiaries
$141
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~71 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)474$96$200
Needle measurement of electrical activity in arm or leg muscles, complete study258$129$301
New patient office visit (45-59 min)227$128$300
Nerve conduction, 9-10 studies182$168$500
Measurement of brain wave activity (eeg), awake and drowsy65$304$656
EEG, extended monitoring45$354$620
Assessment of and care planning for patient with impaired thought processing, typically 60 minutes37$210$300
Nerve conduction, 7-8 studies27$133$400
Office visit, established patient, complex (40-54 min)17$145$250
New patient office visit, complex (60-74 min)15$165$400
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,037
Total received (2018-2024)
Avg $1,291/year across 7 years
Top 29% in FL for neurology
52
Companies
490
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,725 (96.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$312 (3.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,627
2023
$1,116
2022
$1,095
2021
$1,265
2020
$1,136
2019
$1,364
2018
$1,434

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Supernus Pharmaceuticals, Inc.
$835
GENZYME CORPORATION
$672
Amgen Inc.
$637
Novartis Pharmaceuticals Corporation
$606
PFIZER INC.
$545
ABBVIE INC.
$493
AbbVie Inc.
$464
Teva Pharmaceuticals USA, Inc.
$398
Lilly USA, LLC
$313
US WorldMeds, LLC
$292
Lundbeck LLC
$289
Neurocrine Biosciences, Inc.
$282
Amneal Pharmaceuticals LLC
$224
UCB, Inc.
$199
Biogen, Inc.
$197
Allergan, Inc.
$192
ACADIA Pharmaceuticals Inc
$184
Adamas Pharmaceuticals, Inc.
$183
Allergan Inc.
$162
Neurelis, Inc.
$153
Acorda Therapeutics, Inc
$142
Biohaven Pharmaceutical Holding Company Ltd.
$139
CSL Behring
$134
Biohaven Pharmaceuticals, Inc.
$134
EMD Serono, Inc.
$94
SK Life Science, Inc.
$90
Celgene Corporation
$72
Merz Pharmaceuticals, LLC
$70
Sunovion Pharmaceuticals Inc.
$66
Upsher-Smith Laboratories LLC
$64
Avanir Pharmaceuticals, Inc.
$57
MDD US Operations, LLC
$56
ARGENX US, INC.
$53
Almatica Pharma LLC
$51
Otsuka America Pharmaceutical, Inc.
$49
Takeda Pharmaceuticals U.S.A., Inc.
$47
Grifols USA, LLC
$41
IMPEL PHARMACEUTICALS INC.
$38
Arbor Pharmaceuticals, Inc.
$35
Merz North America, Inc.
$32
Alnylam Pharmaceuticals Inc.
$31
UPSHER-SMITH LABORATORIES LLC
$31
MERZ NORTH AMERICA, INC.
$27
Currax Pharmaceuticals LLC
$26
Bausch Health US, LLC
$24
Janssen Pharmaceuticals, Inc
$23
Akcea Therapeutics, Inc.
$20
EISAI INC.
$16
SCILEX PHARMACEUTICALS INC.
$15
AbbVie, Inc.
$15
Avion Pharmaceuticals
$14
Octapharma USA, Inc.
$14
Top 3 companies account for 23.7% of total payments
Associated products mentioned in payments ›
ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Apokyn · Austedo XR · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · Briviact · COMIRNATY · CONTRAVE · CREXONT · DISEASE STATE · Dhivy · Duopa · EMGALITY · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · LEMTRADA · LYRICA · MIGRANAL · MYOBLOC · Mavenclad · NAMZARIC · NAPRELAN · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · OXTELLAR XR · Ongentys · PANZYGA · PAXLOVID · PLEGRIDY · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · REXULTI · RYTARY · TEGSEDI · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · Trudhesa · UBRELVY · VALTOCO · VRAYLAR · VUMERITY · VYEPTI · VYVGART HYTRULO · Vimpat · XEOMIN · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $671 per 100 Medicare services performed
Looking for a neurology in Palm Beach Gardens?
Compare neurologys in the Palm Beach Gardens area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
61
Per 100K population
4.0
County median income
$81,115
Nearest hospital
PALM BEACH GARDENS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Zuniga-Barboni is a clinical cardiology specialist, with above-average Medicare volume (top 25% in FL), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Zuniga-Barboni experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Zuniga-Barboni performed 474 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zuniga-Barboni receive payments from pharmaceutical companies?
Yes. Dr. Zuniga-Barboni received a total of $9,037 from 52 companies across 490 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zuniga-Barboni's costs compare to other neurologys in Palm Beach Gardens?
Dr. Zuniga-Barboni's average Medicare payment per service is $141. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zuniga-Barboni) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →